Floor J. Backes, MD

Articles

Dr. Backes on Experience With PARP Inhibitors in Ovarian Cancer

February 10th 2020

Floor J. Backes, MD, discusses the role of PARP inhibitors as treatment of patients with ovarian cancer and her experience with these agents, such as rucaparib.

Dr. Backes on Quality of Life With PARP Inhibitors in Ovarian Cancer

February 7th 2020

Floor J. Backes, MD, discusses quality of life with PARP inhibitors for patients with ovarian cancer.

Dr. Backes on Toxicity Considerations With PARP Inhibitors in Ovarian Cancer

January 23rd 2020

Floor J. Backes, MD, discusses toxicity considerations with PARP inhibitors in ovarian cancer.

Dr. Backes on Financial Toxicity Considerations in Ovarian Cancer

January 10th 2020

Floor J. Backes, MD, discusses the consideration of financial toxicity when choosing a PARP inhibitor for a patient with ovarian cancer.

Dr. Backes on the FILM Trial in Endometrial Cancer

January 9th 2020

Floor J. Backes, MD, discusses the phase III FILM trial in endometrial cancer.

Dr. Backes on Safety Profile of Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

November 12th 2019

Floor J. Backes, MD, discusses the safety profile from a phase I study looking at lenvatinib and weekly paclitaxel in women with recurrent endometrial cancer.

Dr. Backes on Treatment Selection With PARP Inhibitors in Ovarian Cancer

November 8th 2019

Floor J. Backes, MD, associate professor, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center, discusses treatment selection with PARP inhibitors in ovarian cancer.

Dr. Backes on Next Steps for Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

November 5th 2019

Floor J. Backes, MD, discusses the next steps regarding a phase I trial investigating lenvatinib and weekly paclitaxel in women with recurrent endometrial cancer.

Dr. Backes on Rationale for Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

October 15th 2019

Floor J. Backes, MD, discusses the rationale and results from a phase I study exploring lenvatinib and weekly paclitaxel in women with recurrent endometrial cancer.

Dr. Backes on the Utility of Sentinel Lymph Node Mapping in Cervical Cancer

May 24th 2019

Floor J. Backes, MD, associate professor, Division of Gynecologic Oncology, at The Ohio State University Comprehensive Cancer Center, discusses the utility of sentinel lymph node mapping in patients with cervical cancer.

Dr. Backes on Sentinel Lymph Node Mapping in Cervical Cancer

April 29th 2019

Floor J. Backes, MD, associate professor, Division of Gynecologic Oncology, at The Ohio State University Comprehensive Cancer Center, discusses the use of sentinel lymph node mapping in patients with cervical cancer.

Dr. Backes Discusses PARP Inhibitor Combinations in Ovarian Cancer

March 23rd 2018

Floor J. Backes, MD, associate professor at The Ohio State University Comprehensive Cancer Center, discusses combinations with PARP inhibitors in the treatment of patients with ovarian cancer.